Augmedit
PrivateLast Round
Seed
Nov 1, 2022
Total Funding Raised
$3.85M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Augmedit is a health technology company that develops medical augmented reality software to convert two-dimensional medical imaging into three-dimensional holographic models for surgical planning and intraoperative guidance.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, AR/VR Experiences, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Augmedit Comparables
Compare Augmedit with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medivis | 86% | |
| MediView XR, Inc. | 79% | |
| Surgical Theater | 78% |
Augmedit Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 1, 2022 | ||||
| Grant | Nov 1, 2022 | ||||
| Grant | Oct 9, 2020 | ||||
| Seed | Mar 30, 2020 |
Key People
Founding team and executive leadership
Augmedit Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Revere Partners | Seed |
| European Innovation Council Fund | Grant |
| Revere Partners | Seed |
| European Innovation Council (EIC) Accelerator | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 29, 2026
Grew 24% QoQ from 21 to 26 employees.
- Dec 6, 2025
Launched CE-marked Class IIb module for real-time placement of external ventricular drains.
Augmedit Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Augmedit's valuation, stock price, and market status.
Is Augmedit a public or private company?
Augmedit is a private company.
What is the current stock price of Augmedit?
Augmedit is a private company with no public stock price. No recent secondary market data is available.
How much is Augmedit worth (valuation)?
Valuation information for Augmedit is not publicly available.
Can I buy Augmedit stock?
Augmedit shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Augmedit's last funding round?
Augmedit's most recent funding round was Seed on November 1, 2022.
Who are the main investors in Augmedit?
Key investors in Augmedit include Revere Partners, European Innovation Council.
Will Augmedit IPO soon?
No public IPO plans have been announced for Augmedit.
How can I track Augmedit secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Augmedit's secondary market activity and sign up for updates.